Dr. Hahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
# Dana-Far
Boston, MA 02215Phone+1 617-632-2641Fax+1 617-632-4005
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
- Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1997
- Harvard Medical SchoolClass of 1994
Certifications & Licensure
- MA State Medical License 1996 - 2025
- FL State Medical License 2013 - 2022
Awards, Honors, & Recognition
- Elected member AAP, 2013
- Elected Member The American Society for Clinical Investigation, 2005
Publications & Presentations
PubMed
- 286 citationsThe androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark Pomerantz, Fugen Li, David Y. Takeda, Romina E. Lenci, Apurva Chonkar
Nature Genetics. 2015-11-01 - 65 citationsReprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.Sylvan C. Baca, David Y. Takeda, Ji-Heui Seo, Justin H. Hwang, Sheng-Yu Ku
Nature Communications. 2021-03-30 - 2358 citationsSystematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan Moody
Nature. 2009-11-05
Journal Articles
- Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory CircuitryWilliam C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
- Article Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisWilliam C Hahn, Levi A Garraway, Zhe Li, ScienceDirect
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
- Join now to see all
Abstracts/Posters
- Functional Characterization of E3 Ligases and Their Regulators: Therapeutic Implications for Development of New Proteolysis-Targeting Chimeric Degraders of OncoproteinsWilliam C. Hahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Systematic Characterization of Genes Representing Preferential Molecular Vulnerabilities for Myeloma Cells Compared to Other Neoplasias _ Implications for the Biology ...William C. Hahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- KSQ Therapeutics Raises $80 Million Series C for Cancer TherapiesSeptember 28th, 2018
- Cambridge Startup KSQ Raises Another $80m, Plans to Start Trials of Cancer DrugsSeptember 28th, 2018
- WBUR Invitation: Ask Leaders Your Big-Picture Questions on CancerJanuary 5th, 2018
- Join now to see all
Grant Support
- Druggable Genetic Lesions In Pediatric AstrocytomaNational Cancer Institute2011–2012
- Regulation And Function Of Htert In Human CellsNational Institute On Aging2010–2012
- Investigations On The Role Of The CDK8 Oncogene In Colon CancerNational Cancer Institute2010–2012
- Regulation And Function Of Ikke In Breast Cancer Initiation And MaintenanceNational Cancer Institute2009–2012
- Gene Function Manipulation CoreNational Cancer Institute2009–2012
- Interactions Of The SV40 Small T Antigen And PP2A In Human Cell TransformationNational Cancer Institute2004–2012
- Functional Annotation Of Cancer Genomes: Tcga, Glioblastoma And Ovarian CancerNational Cancer Institute2009–2010
- Integrated Genomic Approaches To Identify And Validate Cancer TargetsNational Cancer Institute2008–2010
- Regulation And Function Of Telomerase In Human CellsNational Institute On Aging2004–2008
- New Models Of Human CancerNational Cancer Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: